The American Journal of Medicine
Volume 122, Issue 10 , Pages 961.e7-961.e13 , October 2009

Long-term Medication Adherence after Myocardial Infarction: Experience of a Community

  • Nilay D. Shah, PhD

      Affiliations

    • Division of Health Care Policy and Research, Mayo Clinic College of Medicine, Rochester, Minn
    • Knowledge and Encounter Research Unit, Mayo Clinic College of Medicine, Rochester, Minn
    • Corresponding Author InformationRequests for reprints should be addressed to Nilay D. Shah, Division of Health Care Policy and Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905
    • ,
  • Shannon M. Dunlay, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Henry H. Ting, MD

      Affiliations

    • Knowledge and Encounter Research Unit, Mayo Clinic College of Medicine, Rochester, Minn
    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Victor M. Montori, MD

      Affiliations

    • Knowledge and Encounter Research Unit, Mayo Clinic College of Medicine, Rochester, Minn
    • Division of Endocrinology Diabetes Metabolism and Nutrition, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Randal J. Thomas, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Amy E. Wagie, BS

      Affiliations

    • Division of Health Care Policy and Research, Mayo Clinic College of Medicine, Rochester, Minn
    • ,
  • Véronique L. Roger, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, Minn
    • Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn

References 

  1. LaBresh KA, Ellrodt AG, Gliklich R, et al. Get with the guidelines for cardiovascular secondary prevention—pilot results. Arch Intern Med. 2004;164:203–209
  2. Liem SS, van der Hoeven BL, Oemrawsingh PV, et al. MISSION! (Optimization of acute and chronic care for patients with acute myocardial infarction). Am Heart J. 2007;153:14.e1–14.e11
  3. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction—the guidelines applied in practice (GAP) initiative. JAMA. 2002;287:1269–1276
  4. Rogers AM, Ramanath VS, Grzybowski M, et al. The association between guideline-based treatment instructions at the point of discharge and lower 1-year mortality in Medicare patients after acute myocardial infarction: the American College of Cardiology's Guidelines Applied in Practice (GAP) initiative in Michigan. Am Heart J. 2007;154:461–469
  5. Gouya G, Reichardt B, Ohrenberger G, Wolzt M. Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy. Eur J Epidemiol. 2007;22:145–149
  6. Bradley EH, Herrin J, Elbel B, et al. Hospital quality for acute myocardial infarction—correlation among process measures and relationship with short-term mortality. JAMA. 2006;296:72–78
  7. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842–1847
  8. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–186
  9. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117:1028–1036
  10. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462–467
  11. Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117:73–81
  12. Ho PM, Spertus JA, Masoudi FA, et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842–1847
  13. Melton LJ. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71:266–274
  14. Luepker RV, Apple FS, Christenson RH, et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation. 2003;108:2543–2549
  15. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: Joen-Wright PSG Inc; 1982;
  16. Roger VL, Killian J, Henkel M, et al. Coronary disease surveillance in Olmsted County objectives and methodology. J Clin Epidemiol. 2002;55:593–601
  17. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med. 2002;136:341–348
  18. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383
  19. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–186
  20. Daugherty SL, Ho PM, Spertus JA, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med. 2008;168:485–491discussion 492
  21. Wutoh AK, Elekwachi O, Clarke-Tasker V, et al. Assessment and predictors of antiretroviral adherence in older HIV-infected patients. J Acquir Immune Defic Syndr. 2003;33(Suppl 2):S106–S114
  22. Shalansky S, Levy A, Ignaszewski A. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother. 2004;38:1363–1368
  23. Snow V, Barry P, Fihn SD, et al. Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2004;141:562–567
  24. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366–1374
  25. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:E1–E211
  26. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110:1168–1176
  27. Anderson JL. ACC/AHA 2007 guide lines for the management of patients with unstable Angina/Non-ST-Elevation myocardial infarction—executive summary. J Am Coll Cardiol. 2007;50:652–726
  28. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. Circulation. 2005;112:E154–E235
  29. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345:892–902
  30. Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol. 2008;51(17):1619–1631
  31. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction (Combined experience of randomized clinical trials). JAMA. 1988;260:945–950
  32. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116:682–692
  33. Jolliffe JA, Rees K, Taylor RS, et al. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2000;CD001800
  34. Brochu M, Poehlman ET, Savage P, et al. Modest effects of exercise training alone on coronary risk factors and body composition in coronary patients. J Cardiopulm Rehabil. 2000;20:180–188
  35. Dylewicz P, Bienkowska S, Szczesniak L, et al. Beneficial effect of short-term endurance training on glucose metabolism during rehabilitation after coronary bypass surgery. Chest. 2000;117:47–51
  36. Lavie CJ, Milani RV. Adverse psychological and coronary risk profiles in young patients with coronary artery disease and benefits of formal cardiac rehabilitation. Arch Intern Med. 2006;166:1878–1883
  37. Freemantle N, Cleland J, Young P, et al. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730–1737
  38. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels (The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group). N Engl J Med. 1998;339:1349–1357
  39. Pedersen TR, Wilhelmsen L, Faergeman O, et al. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol. 2000;86:257–262
  40. Witt BJ, Jacobsen SJ, Weston SA, et al. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol. 2004;44:988–996
  41. O'Connor GT, Buring JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;80:234–244

 Funding: Mayo Foundation for Education and Research, National Institute of Health, (ROI HL59205), Rochester Epidemiology Project Grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (ROI AR30582).

 Conflict of Interest: None.

 Authorship: NDS had access to data throughout the study and takes responsibility for the analysis. All other authors played important roles in conceptualization, data interpretation, writing, and critical revisions for this manuscript.

PII: S0002-9343(09)00281-2

doi: 10.1016/j.amjmed.2008.12.021

The American Journal of Medicine
Volume 122, Issue 10 , Pages 961.e7-961.e13 , October 2009

Article Tools

* Image Usage & Resolution